Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial

Cancer Prevention Research

Volumn 3, Issue 6, 2010, Pages 764-775

  Bobe, Gerd ^a   Albert, Paul S ^a   Sansbury, Leah B ^a   Lanza, Elaine ^a   Schatzkin, Arthur ^a   Colburn, Nancy H ^a   Cross, Amanda J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONOL; INTERLEUKIN 6; ISORHAMNETIN; KAEMPFEROL; QUERCETIN; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; FLAVONOL DERIVATIVE; IL6 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER PREVENTION; CANCER RECURRENCE; CANCER RISK; CARCINOGENESIS; CLINICAL TRIAL; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; FEMALE; FRUIT; HIGH FIBER DIET; HUMAN; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; VEGETABLE; ADENOCARCINOMA; ADENOMA; ADENOMATOUS POLYPS; ADMINISTRATION AND DOSAGE; BLOOD; COLONIC NEOPLASMS; COLONIC POLYPS; COLORECTAL NEOPLASMS; DIET THERAPY; DIETARY FIBER; FOLLOW UP; INFLAMMATION; MEDICAL RECORD; MIDDLE AGED; PHYTOTHERAPY; RISK; SECONDARY PREVENTION;

ADENOCARCINOMA; ADENOMA; ADENOMATOUS POLYPS; ADULT; AGED; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; BIOLOGICAL MARKERS; COLONIC NEOPLASMS; COLONIC POLYPS; COLORECTAL NEOPLASMS; DIET RECORDS; DIET, FAT-RESTRICTED; DIETARY FIBER; FEMALE; FLAVONOLS; FOLLOW-UP STUDIES; FRUIT; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERVENTION STUDIES; MALE; MIDDLE AGED; PHYTOTHERAPY; RECURRENCE; RISK; VEGETABLES; BIOMARKERS; SECONDARY PREVENTION;

EID: 77953497168     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0161     Document Type: Article

References (46)

1. Gill S, Sinicrope FA. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure? Sem Oncol 2005;32:24-34.
2. American Cancer Society. Colorectal cancer facts & figures 2008-2010. Atlanta (GA): American Cancer Society; 2008.
3. Winawer SJ, Zauber AG, Fletcher RH, et al, U.S. Multi-Society Task Force on Colorectal cancer. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the U.S. Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006;130:1872-85.
4. Kristal AR, Lippman SM. Nutritional prevention of cancer: new directions for an increasingly complex challenge. JNCI 2009;101:363-5.
5. Bobe G, Sansbury LB, Albert PS, et al. Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev 2008;17:1344-53.
6. Chun OK, Chung SJ, Song WO. Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr 2007;137:1244-52.
7. Ferguson LR, Philpott M. Cancer prevention by dietary bioactive components that target the immune response. Curr Cancer Drug Targets 2007;7:459-65.
8. Camuesco D, Comalada M, Rodriguez-Cabezas ME, et al. The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br J Pharmacol 2004;143:908-18.
9. Kwon KH, Murakami A, Tanaka T, Ohigashi H. Dietary rutin but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem Pharmacol 2005;69:395-406.
10. CamuescoD, Comalada M, Concha A, et al. Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis. Clin Nutr 2006;25:466-76.
11. Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Res 2002;4 Suppl. 3:S233-42.
12. Naugler W, Karin M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 2008;14:109-19.
13. Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitisassociated cancer. Cancer Cell 2009;15:103-13.
14. Song Y, Manson JE, Buring JE, et al. Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J Am Coll Nutr 2005;24:376-84.
15. Chun OK, Chung S-J, Claycombe KJ, Song WO. Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults. J Nutr 2008;138:753-60.
16. Kim S, Keku TO, Martin C, et al. Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res 2008;68:323-8.
17. Il'yasova D, Colbert LH, Harris TB, et al. Circulating levels of inflammatory markers and cancer risk in the Health Aging and Body Composition Cohort. Cancer Epidemiol Biomarkers Prev 2005;14:2413-8.
18. Heikkilä K, Ebrahim S, Lawlor DA. Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur J Cancer 2008;44:937-45.
19. Lanza E, Schatzkin A, Ballard-Barbash R, et al. The Polyp Prevention Trial II: dietary intervention program and participant baseline dietary characteristics. Cancer Epidemiol Biomarkers Prev 1996;5:385-92.
20. Schatzkin A, Lanza E, Corle D, et al, Polyp Prevention Trial Study Group. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med 2000;342:1149-55.
21. Lanza E, Schatzkin A, Daston C, et al. Implementation of a 4-y, highfiber, high-fruit-and-vegetable, low-fat dietary intervention: results of dietary changes in the Polyp Prevention Trial. Am J Clin Nutr 2001;74:387-401.
22. Block G, Woods M, Potosky A, Clifford C. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990;43:1327-35.
23. U.S. Department of Agriculture, Agricultural Research Service. USDA database for the flavonoid content of selected foods, Release 2.1, 2007. Nutrient Data Laboratory web site: http//www.nal.usda.gov/fnic/foodcomp/Data/ Flav/Flav02-1.pdf.
24. Caan BJ, Lanza E, Schatzkin A, et al. Does nutritionist review of a self-administered food frequency questionnaire improve data quality. Public Health Nutr 1999;2:565-9.
25. Richter M, Ebermann R, Marian B. Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling. Nutr Cancer 1999;34:88-99.
26. Jeong JH, An JY, Kwon YT, Rhee JG, Le YJ. Effects of low dose quercetin: cancer cell specific inhibition of cell cycle progression. J Cell Biochem 2009;106:73-82.
27. Smith-Warner SA, Elmer PJ, Fosdick L, et al. Fruits, vegetables, and adenomatous polyps: the Minnesota Cancer Prevention Research Unit case-control study. Am J Epidemiol 2002;342:1149-55.
28. Miki C, Tonouchi H, Wakuda R, et al. Intra-tumoral interleukin-6 down-regulation system and genetic mutations of tumor suppressor genes in colorectal carcinoma. Cancer 2002;94:1584-92.
29. Kaminska J, Nowacki MP, Kowalska M, et al. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I - an independent prognostic factor. Tumor Biol 2005;26:186-94.
30. Cui G, Yuan A, Goll R, et al. Distinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma-carcinoma sequence. Cancer Immunol Immunother 2007;56:1993-2001. (Pubitemid 47512619)
31. Schetter AJ, Nguyen GH, Bowman ED, et al. Association of inflammation-related and microRNA gene expression with cancer specific mortality of colon adenocarcinoma. Clin Cancer Res 2009;15:5878-87.
32. Heikkilä K, Harris R, Lowe G, et al. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta analysis. Cancer Causes Control 2009;20:15-26.
33. Mentor-Marcel RM, Bobe G, Barrett KG, et al. Inflammation-associated serum and colon markers as indicators of dietary attenuation of colon carcinogenesis in ob/ob mice. Cancer Prev Res 2009;2:60-9.
34. Lopez-Garcia E, Schulze MB, Fung TT, et al. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2004;80:1029-35.
35. Nettleton JA, Steffen LM, Mayer-Davis EJ, et al. Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2006;83:1369-79.
36. Jung W-J, Sung M-K. Effects of major dietary antioxidants on inflammatory markers of RAW 264.7 macrophages. Biofactors 2004;21:113-7.
37. Kempuraj D, Madhappan B, Christodoulou S, et al. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase Cθ phosphorylation in human mast cells. Br J Pharmacol 2005;145:934-44. (Pubitemid 41129015)
38. Liu J, Li X, Yue Y, et al. The inhibitory effect of quercetin on IL-6 production by LPS-stimulated neutrophils. Cell Mol Immunol 2005;2:455-60.
39. Boots AW, Drent M, Swennen EL, Moonen HJ, Bast A, Haenen GR. Antioxidant status associated with inflammation in sarcoidosis: a potential role for antioxidants. Respir Med 2009;103:364-72.
40. Chan MM, Fong D, Soprano KJ, Holmes WF, Heverling H. Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents. J Cell Physiol 2003;194:63-70. (Pubitemid 35424228)
41. Caan B, Ballard-Barbash R, Slattery ML, et al. Low energy reporting may increase in intervention participants enrolled in dietary intervention trials. J Am Diet Assoc 2004;104:357-66. (Pubitemid 38296632)
42. Hennning C, Rink L, Fagin U, et al. The influence of naturally occurring heterophilic anti-immunoglobulin antibodies on direct measurement of serum proteins using sandwich ELISAs. J Immunol Methods 2000;235:71-80. (Pubitemid 30089785)
43. Martins TB, Pasi BM, Litwin CM, Hill HR. Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum. Clin Diagn Lab Immunol 2004:11L325-9.
44. de Jager W, Prakken BJ, Bijlsma JWJ, et al. Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. J Immunol Methods 2005;300:124-35.
45. Toedter G, Hayden K, Wagner C, Brodmerkel C. Multiplex cytokine analysis in human serum: an evaluation of technologies for the simultaneous detection of eight analytes. Clin Vaccine Immunol 2008;15:42-8. (Pubitemid 351966532)
46. Enewold L, Mechanic LE, Bowman ED, et al. Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 2009;18:215-22.